IP Library › Assignment 023962/0177
Patent Assignment
Reel/Frame 023962/0177

Assignment of Assignor's Interest

Recorded: 2010-02-19 Pages: 6
Assignor
SANTARIS PHARMA A/S
Executed: 2009-10-14
Assignees
ENZON PHARMACEUTICALS, INC.
685 ROUTE 202/206, BRIDGEWATER, NEW JERSEY, 08807
SANTARIS PHARMA A/S
KOGLE ALLE 6, HOERSHOLM, DK-2970, DENMARK
Covered Property (1)
Lna Antagonists Targeting the Androgen Receptor
Patent: 7,737,125 →
Application: 12/324,033 →
Publication: US 2009/0181916
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 27, 2009
From: WORM, JESPER
To: SANTARIS PHARMA A/S
Reel/Frame 022322/0932 →
Assignment of Assignor's Interest Apr 10, 2015
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 035384/0923 →
Merger and Change of Name Apr 13, 2015
From: SANTARIS PHARMA A/S; ROCHE INNOVATION CENTER COPENHAGEN A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 035421/0435 →
Corrective Assignment to Correct the Redacted Schedule of the Executed Assignment Document Previously Recorded at Reel: 035384 Frame: 0923. Assignor(S) Hereby Confirms the Assignment. Feb 16, 2016
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 037821/0938 →